Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114594 · ClinicalTrials.gov registry record
Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
A clinical trial, sponsored by The Rogosin Institute.
- Completed
- Registry status
- 42
- Enrollment target
NCT01114594 is a clinical trial that has completed, run by The Rogosin Institute. The registered enrollment target is 42 participants.
The verdict
NCT01114594 has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The aim of this pilot project is to assess the potential of urine micro-RNAs (miRNA) as biomarkers for characterizing patients with autosomal dominant polycystic kidney disease (ADPKD) compared with patients with other causes of chronic kidney disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114594
The ClinicalTrials.gov registry entry for NCT01114594 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01114594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01114594 about?
NCT01114594 is a clinical study titled "Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease". The aim of this pilot project is to assess the potential of urine micro-RNAs (miRNA) as biomarkers for characterizing patients with autosomal dominant polycystic kidney disease (ADPKD) compared with patients with other causes of chronic kidney disease.
What is the current status of trial NCT01114594?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2010-04. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01114594?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.